Screening for medium chain acyl-CoA dehydrogenase deficiency has still not been evaluated
- 13 January 2001
- Vol. 322 (7278) , 112
- https://doi.org/10.1136/bmj.322.7278.112
Abstract
EDITOR—Every baby born in the United Kingdom is screened for phenylketonuria and congenital hypothyroidism at 6-14 days of age. Several screening laboratories now use tandem mass spectrometry for estimating blood phenylalanine concentration. Tandem mass spectrometry can assay simultaneously, in the same sample, many other metabolites and can thus potentially detect other metabolic disorders, including medium chain acyl-CoA dehydrogenase deficiency. Medium chain acyl-CoA dehydrogenase deficiency is almost as common as phenylketonuria, affecting roughly 1:15 000 births in the United Kingdom. Infants with …Keywords
This publication has 3 references indexed in Scilit:
- Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosisArchives of Disease in Childhood, 1999
- Newborn screening for inborn errors of metabolism: a systematic review.1997
- Neonatal screening for inborn errors of metabolism: cost, yield and outcome.Health Technology Assessment, 1997